Business
Novo Nordisk shared an increase in new obesity results
Novo Nordisk’s shares increased sharply after the Danish pharmaceutical giant said a test weight loss shot helped patients lose 22% of body weight in a clinical trial.
Novo Nordisk’s shares increased sharply after the Danish pharmaceutical giant said a test weight loss shot helped patients lose 22% of body weight in a clinical trial.
